Guchelaar HJ - Search Results

1

Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study.

Joosse A, Koomen ER, Casparie MK, Herings RM, Guchelaar HJ, Nijsten T. Joosse A, et al. Among authors: guchelaar hj. J Invest Dermatol. 2009 Nov;129(11):2620-7. doi: 10.1038/jid.2009.201. Epub 2009 Jul 9. J Invest Dermatol. 2009. PMID: 19587697 Free article.

2

The risk of cancer in users of statins.

Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ, Guchelaar HJ. Graaf MR, et al. Among authors: guchelaar hj. J Clin Oncol. 2004 Jun 15;22(12):2388-94. doi: 10.1200/JCO.2004.02.027. J Clin Oncol. 2004. PMID: 15197200

3

Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?

Koomen ER, Joosse A, Herings RM, Casparie MK, Bergman W, Nijsten T, Guchelaar HJ. Koomen ER, et al. Among authors: guchelaar hj. Eur J Cancer. 2007 Nov;43(17):2580-9. doi: 10.1016/j.ejca.2007.09.004. Epub 2007 Oct 22. Eur J Cancer. 2007. PMID: 17950596

4

Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study.

Koomen ER, Joosse A, Herings RM, Casparie MK, Guchelaar HJ, Nijsten T. Koomen ER, et al. Among authors: guchelaar hj. Ann Oncol. 2009 Feb;20(2):358-64. doi: 10.1093/annonc/mdn589. Epub 2008 Aug 25. Ann Oncol. 2009. PMID: 18725391 Free article.

5

Does use of estrogens decrease the Breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy.

Koomen ER, Joosse A, Herings RM, Casparie MK, Guchelaar HJ, Nijsten T. Koomen ER, et al. Among authors: guchelaar hj. Melanoma Res. 2009 Oct;19(5):327-32. doi: 10.1097/CMR.0b013e32832f159c. Melanoma Res. 2009. PMID: 19593232

6

Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

Koomen ER, Herings RM, Guchelaar HJ, Nijsten T. Koomen ER, et al. Among authors: guchelaar hj. Cancer Epidemiol. 2009 Nov;33(5):391-5. doi: 10.1016/j.canep.2009.10.005. Epub 2009 Nov 7. Cancer Epidemiol. 2009. PMID: 19896919

7

Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.

Dezentjé VO, van Blijderveen NJ, Gelderblom H, Putter H, van Herk-Sukel MP, Casparie MK, Egberts AC, Nortier JW, Guchelaar HJ. Dezentjé VO, et al. Among authors: guchelaar hj. J Clin Oncol. 2010 May 10;28(14):2423-9. doi: 10.1200/JCO.2009.25.0894. Epub 2010 Apr 12. J Clin Oncol. 2010. PMID: 20385997

8

Epidemiology of extracutaneous melanoma in the Netherlands.

Koomen ER, de Vries E, van Kempen LC, van Akkooi AC, Guchelaar HJ, Louwman MW, Nijsten T, Coebergh JW. Koomen ER, et al. Among authors: guchelaar hj. Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1453-9. doi: 10.1158/1055-9965.EPI-09-1267. Epub 2010 May 25. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20501769

9

Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma.

Siiskonen SJ, Koomen ER, Visser LE, Herings RM, Guchelaar HJ, Stricker BH, Nijsten TE. Siiskonen SJ, et al. Among authors: guchelaar hj. Eur J Clin Pharmacol. 2013 Jul;69(7):1437-44. doi: 10.1007/s00228-013-1476-x. Epub 2013 Mar 8. Eur J Clin Pharmacol. 2013. PMID: 23471440

10

Outcomes of an antimicrobial control program in a Dutch hospital.

Kweekel DM, le Cessie S, Guchelaar HJ, Vermeij P, Van den Broek PJ, Twiss IM. Kweekel DM, et al. Among authors: guchelaar hj. Am J Health Syst Pharm. 2004 Aug 15;61(16):1702-6. doi: 10.1093/ajhp/61.16.1702. Am J Health Syst Pharm. 2004. PMID: 15540484 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

462 results

Search Page